Mettler-Toledo International (MTD)
$680.74
7.36 (1.07%)
MTD Stock Quote Delayed 15 Minutes
Previous Close
$680.74
Market Cap
17.29B
PE Ratio
47.47
EPS
14.34
Volume (Avg. Vol.)
121,400
Day's Range
680.25 - 690.62
52-Week Range
500.74 - 873.51
Dividend & Yield
N/A (N/A)
MTD Stock Predictions, Articles, and Mettler-Toledo International News
3 Stocks to Watch on Friday: Expedia Inc (EXPE), Mettler-Toledo International Inc. (MTD) and Mohawk Industries, Inc. (MHK)
Expedia (EXPE) shares plummet on earnings miss, Mettler-Toledo's (MTD) profit beats estimates and Mohawk Industries's (MHK) revenue impressed.
Quant Score Keep Mettler-Toledo International (MTD) a Buy
The current recommendation of Buy for Mettler-Toledo International Inc (NYSE:MTD) is computed using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. MTD has recently seen its Portfolio Grader rating downgraded over the last month from a Strong Buy to a Buy.
Healthy Quant Score Make Mettler-Toledo International (MTD) a Buy
Mettler-Toledo International Inc (NYSE:MTD) is a component of the 32 company Life Sciences Tools & Services GICS industry group, which is a segment of the 781 company GICS Health Care sector. The market value of MTD is $16.1 billion which places it in the top 25% of its industry group. Portfolio Grader's current ranking for MTD puts it 11 among the 32 companies in this industry group, placing it in the top half; in the top quartile of the sector with a ranking of 106 among the 781 companies in the sector, and number 676 in the nearly 5,000 company Portfolio Grader universe.
Quant Score Keeps Mettler-Toledo International (MTD) Shares a Buy
Mettler-Toledo International Inc (NYSE:MTD) is a constituent of the 33 company Life Sciences Tools & Services GICS industry group, which is a segment of the 782 company GICS Health Care sector. The market value of MTD is $15.9 billion which falls in the top quarter of its industry group. Portfolio Grader's current ranking for MTD puts it 8 among the 33 companies in this industry group, placing it among the leaders; in the top quartile of the sector with a ranking of 109 among the 782 companies in the sector, and number 697 in the nearly 5,000 company Portfolio Grader universe.
Outstanding Quant Score Makes Mettler-Toledo International (MTD) a Strong Buy
As one of the 785 companies in the GICS Health Care sector Mettler-Toledo International Inc (NYSE:MTD) is a component of the 33 company Life Sciences Tools & Services GICS industry group within this sector. MTD has a market value of $16.5 billion which is in the top 25% of its industry group. Portfolio Grader's current ranking for MTD puts it 5 among the 33 companies in this industry group, putting in the top quartile; among the sector leaders with a ranking of 35 among the 785 companies in the sector, and number 256 in the nearly 5,000 company Portfolio Grader universe.
Mettler-Toledo International (MTD) a Strong Buy on High-Level Earnings Momentum
Currently, Mettler-Toledo International Inc (NYSE:MTD) has a Strong Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing system. The current Portfolio Grader recommendation on the shares has been in place for 5 months.
High-Level Earnings Momentum Makes Mettler-Toledo International (MTD) a Strong Buy
Currently, Mettler-Toledo International Inc (NYSE:MTD) has a Strong Buy using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking MTD has had from Portfolio Grader for 5 months.
Top-End Measures for Earnings Growth Make Mettler-Toledo International (MTD) a Strong Buy
The current recommendation of Strong Buy for Mettler-Toledo International Inc (NYSE:MTD) has been derived by using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 5 months.
Strong Buy Rating on Mettler-Toledo International (MTD) Stock Retained
Portfolio Grader currently ranks Mettler-Toledo International Inc (NYSE:MTD) a Strong Buy. Using Louis Navellier's investing system, this analytical tool assesses stocks with fundamental and quantitative metrics. The current Portfolio Grader recommendation on the shares has been in place for 4 months.
Strong Buy Rating on Mettler-Toledo International (MTD) Stock Retained
Portfolio Grader currently ranks Mettler-Toledo International Inc (NYSE:MTD) a Strong Buy. Using Louis Navellier's investing system, this analytical tool assesses stocks with fundamental and quantitative metrics. The current Portfolio Grader recommendation on the shares has been in place for 4 months.
4 Life Sciences Tools & Services Stocks to Buy Now
This week, 4 Life Sciences Tools & Services stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
3 Life Sciences Tools & Services Stocks to Buy Now
The grades of 3 Life Sciences Tools & Services stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
3 Life Sciences Tools & Services Stocks to Buy Now
3 Life Sciences Tools & Services stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
Biggest Movers in Technology Stocks Now – IMPV ISIL ELLI MKSI
Technology stocks finished down broadly on Wall Street on Monday, with the sector seeing an overall decline of 0.2%.
Hottest Technology Stocks Now – IMPV MTD MTSI LOGI
Technology stocks rose broadly on Wall Street on Friday, with the sector seeing an overall increase of 0.5%.
Hottest Technology Stocks Now – SMCI OVTI SLH DSGX
Technology stocks finished up 0.2% on Wall Street today.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
